# RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.

> **NCT05127798** · — · UNKNOWN · sponsor: **Grupo Argentino de Tratamiento de la Leucemia Aguda** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia, Adult

## Interventions

- **OTHER:** Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.

## Key facts

- **NCT ID:** NCT05127798
- **Lead sponsor:** Grupo Argentino de Tratamiento de la Leucemia Aguda
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127798, "RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05127798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*